$2.60 -$0.03 (-1.0%)

02:31 PM EDT on 06/02/20

Marinus Pharmaceuticals Inc (NASDAQ:MRNS)

CAPS Rating: 2 out of 5

Current Price $2.60 Mkt Cap $269.2M
Open $2.61 P/E Ratio 0.00
Prev. Close $2.62 Div. (Yield) $0.00 (0.0%)
Daily Range $2.45 - $2.65 Volume 900,905
52-Wk Range $0.77 - $4.83 Avg. Daily Vol. 911,929

Caps

How do you think NASDAQ:MRNS will perform against the market?

Add Stock to CAPS Watchlist

All Players

24 Outperform
3 Underperform
 

All-Star Players

6 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:MRNS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

superstar2 (99.30)
Submitted September 23, 2016

Simply stated, it will go higher... my methodology is top secret however, so no explanations will be granted on this one.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:MRNS VS S&P 500 (SPY)

NASDAQ:MRNS Summary

Fools bullish on NASDAQ:MRNS are also bullish on:

Fools bearish on NASDAQ:MRNS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MRNS.

Recs

0
Member Avatar Bigsef77 (69.09) Submitted: 5/5/2020 3:59:33 PM : Outperform Start Price: $3.51 NASDAQ:MRNS Score: -39.73

Innovative seizure disorder therapy.

Recs

0
Member Avatar mdriver78 (71.21) Submitted: 1/24/2020 9:09:18 AM : Outperform Start Price: $2.07 NASDAQ:MRNS Score: +31.15

In a recent update, the company announced that it’s on track to wrap up a pivotal Phase 3 clinical trial by Q3 2020.
This trial showcases Marinus’ compound ganaxolone — designed to regulate a neurotransmitter in the brain called GABAA. The trial is in patients with a disease called CDKL5 deficiency disorder (CDD), which causes seizures and holds back cognitive development for over 12,500 children in the U.S. and Europe.

Recs

1
Member Avatar superstar2 (99.30) Submitted: 9/23/2016 3:38:42 PM : Outperform Start Price: $2.19 NASDAQ:MRNS Score: -22.95

Simply stated, it will go higher... my methodology is top secret however, so no explanations will be granted on this one.

Leaderboard

Find the members with the highest scoring picks in MRNS.

Score Leader

sublimeinvestor

sublimeinvestor (31.60) Score: +124.55

The Score Leader is the player with the highest score across all their picks in MRNS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WildShaman 79.74 7/9/2018 Underperform 5Y $7.47 -65.06% +11.04% +76.10 0 Comment
TheGreatSatan 100.00 3/19/2019 Underperform 5Y $3.93 -33.59% +8.32% +41.90 0 Comment
portefeuille2 99.27 8/17/2016 Outperform 5Y $1.48 +76.35% +40.87% +35.48 0 Comment
RUNNER71 70.76 8/15/2016 Outperform 1Y $1.50 +74.00% +40.29% +33.71 0 Comment
mdriver78 71.21 1/27/2020 Outperform 5Y $2.07 +25.79% -5.36% +31.15 1 Comment
gunda7907 < 20 6/13/2016 Outperform 5Y $1.50 +74.00% +46.76% +27.24 0 Comment
sdhwang422 84.78 7/7/2016 Outperform 5Y $1.55 +68.93% +47.08% +21.85 0 Comment
oscillation 74.31 6/13/2016 Outperform 5Y $1.57 +66.52% +46.86% +19.65 1 Comment
orth5family < 20 9/29/2016 Outperform 5Y $1.86 +40.32% +41.91% -1.59 0 Comment
superstar2 99.30 9/23/2016 Outperform 5Y $2.19 +19.12% +42.07% -22.95 2 Comments

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MRNS.